StockGuru Stocks to Watch for Tuesday, May 6, 2008 Featuring Oncolin Therapeutics, Essential Innovations Technology, Euoko, and Metro One Development
Oncolin Therapeutics, Inc. (OTCBB: OCOL) Oncolin Therapeutics, Inc. (OTCBB: OCOL) - Monday’s shares closed down 14.29% to $0.30. 23,093 shares were traded. Oncolin Therapeutics, Inc. announced May 5th that Dr Randall K. Johnson agreed to join the Scientific Advisory Board of the company joining a growing number of illustrious oncologists and cancer drug developers. Dr Johnson began his career as section Head of the Experimental Chemotherapy at the National Cancer Institute. Most of his accomplishments occurred over more than twenty years at Glaxo SmithKline where he held various senior positions in oncology culminating in Oncology Group Director. Among the many…